Table 2.
Variable | n (%) |
---|---|
Female sex | 88 (41) |
ABO genotypesb | |
Carriers of four-variant haplotype | 57 (27) |
Wild type for c.260insG variant | 50 (23) |
Homozygous for c.260insG variant | 48 (22) |
All other | 81 (38) |
Blood typec | |
A | 107 (50) |
Od | 50 (23) |
B | 35 (16) |
AB | 22 (10) |
Otitis media typee | |
RAOMf | 191 (89) |
COMEg | 148 (69) |
Both RAOM and COMEh | 125 (58) |
Average age was 12.9 ± 3.3 years.
A total of 22 (10%) probands are both carriers of the 4-variant haplotype and homozygous for c.260insG.
Known proportions for each blood type in the general Finnish population using a sample of n = 5536 (ref. 4): A (44%); O (31%); B (17%); AB (8%).
The 95% CI for type O does not overlap in the two groups using the binomial test, with lower frequency in OM probands—OM 95% CI: 17.9–29.6; general population 95% CI: 29.8–32.2.
Probands were ascertained upon referral for ventilation tube insertion for OM. COME was diagnosed for middle ear effusion >2 months, whereas RAOM was diagnosed for those with >3 AOM episodes in 6 months or >4 AOM episodes in 12 months.
For model RAOM∼Age+Sex+TypeO, βTypeO = −0.098 ± 0.046, p = 0.03.
For model COME∼Age+Sex+TypeA, βTypeA = 0.134 ± 0.061, p = 0.03.
For model BothRAOM/COME∼Age+Sex+TypeA, βTypeA = 0.131 ± 0.066, p = 0.0495 and βSex = −0.160 ± 0.067, p = 0.02. This suggests that increased susceptibility to having both RAOM and COME due to blood type A is more predominant in males.
AOM, acute otitis media; CI, confidence interval; COME, chronic otitis media with effusion; RAOM, recurrent acute otitis media.